EPISODE · Sep 28, 2020 · 3 MIN
More vaccines enter Phase III trials, researchers are learning more about the long-term impact of Covid-19, and risk calculation becomes increasingly difficult as the country reopens – Tech in Two.
from What's New · host SpokenLayer
Catch up on the most important news today in 2 minutes or less. Get even more news you can use with the Tech in Two newsletter. Sign up here: https://www.wired.com/tt Learn about your ad choices: dovetail.prx.org/ad-choices
NOW PLAYING
More vaccines enter Phase III trials, researchers are learning more about the long-term impact of Covid-19, and risk calculation becomes increasingly difficult as the country reopens – Tech in Two.
No transcript for this episode yet
Similar Episodes
Nov 14, 2025 ·32m
Oct 31, 2025 ·30m
Oct 23, 2025 ·23m
Oct 13, 2025 ·27m
Oct 3, 2025 ·26m